Advanced Diagnostics News Today

NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report)’s share price rose 8.8% during trading on Wednesday . The company traded as high as $14.37 and last traded at $14.32. Approximately 505,729 shares changed hands during trading, a decline of 41% from the average daily volume of 858,388 shares. The stock had previously closed at $13.16. Analyst […]

NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) has received a consensus rating of “Moderate Buy” from the ten research firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and nine have issued a buy rating on the company. The average 12 month […]

Mckinley Capital Management LLC increased its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 32.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 183,610 shares of the medical research company’s stock after acquiring an additional 45,260 shares during the period. Mckinley […]

Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating and nine have given a buy rating to the company. The average 1-year price […]

Lisanti Capital Growth LLC acquired a new position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) in the fourth quarter, Holdings Channel reports. The firm acquired 212,935 shares of the medical research company’s stock, valued at approximately $3,445,000. A number of other hedge funds and other institutional investors have also recently added to or reduced their […]

Lisanti Capital Growth LLC acquired a new position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 212,935 shares of the medical research company’s stock, valued at approximately $3,445,000. Lisanti Capital Growth LLC owned approximately 0.17% […]

Handelsbanken Fonder AB lifted its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 7.0% during the fourth quarter, Holdings Channel.com reports. The firm owned 19,900 shares of the medical research company’s stock after acquiring an additional 1,300 shares during the period. Handelsbanken Fonder AB’s holdings in NeoGenomics were worth $322,000 as of […]

Benchmark reaffirmed their buy rating on shares of NeoGenomics (NASDAQ:NEO – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. The firm currently has a $18.00 price objective on the medical research company’s stock. Other research analysts also recently issued reports about the company. William Blair restated an outperform rating […]

Benchmark reissued their buy rating on shares of NeoGenomics (NASDAQ:NEO – Free Report) in a report released on Wednesday, Benzinga reports. The brokerage currently has a $18.00 price target on the medical research company’s stock. A number of other brokerages have also commented on NEO. Piper Sandler increased their price objective on NeoGenomics from $18.00 […]

Mach 1 Financial Group LLC lowered its position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 33.5% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 23,228 shares of the medical research company’s stock after selling 11,701 shares during the quarter. Mach 1 Financial Group LLC’s holdings in NeoGenomics were worth $376,000 as of […]